Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Malignant Solid Neoplasm × dinaciclib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 3 Triple Negative Breast Neoplasms 2 Lymphoma, Non-Hodgkin 2 Breast Neoplasms 2 Recurrence 1 Pancreatic Neoplasms 1 Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Breast Neoplasms, Male 1 Advanced Malignant Solid Neoplasm 1

Interventions

veliparib 1 pamiparib 1 dinaciclib 1 cabozantinib 1 Pharmacogenomic Variants 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01434316 2026-03-18

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Active not recruiting

Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡